News

Landos Biopharma Chairman and CEO Wins Research Excellence Award

Read More

New Insights on NLRX1 as a New Therapeutic Target for IBD

Read More

Landos Biopharma Raises $10 Million in Series A Financing

Read More

Landos featured in BioWorld

Read More

BT-11: Oral Therapeutic Treatment for Inflammatory Bowel Disease

Read More

Landos Founder Named 2017 Innovator of the Year

Read More